[HTML][HTML] Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma

IM Tenente, MN Hayes, MS Ignatius, K McCarthy… - Elife, 2017 - elifesciences.org
Rhabdomyosarcoma (RMS) is a pediatric malignacy of muscle with myogenic regulatory
transcription factors MYOD and MYF5 being expressed in this disease. Consensus in the …

[HTML][HTML] SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state

JY Hsu, EP Danis, S Nance, JH O'Brien, AL Gustafson… - Cell reports, 2022 - cell.com
Rhabdomyosarcoma (RMS) is a pediatric muscle sarcoma characterized by expression of
the myogenic lineage transcription factors (TFs) MYOD1 and MYOG. Despite high …

Dysregulated myogenesis in rhabdomyosarcoma

YY Peter, DC Guttridge - Current Topics in Developmental Biology, 2018 - Elsevier
Rhabdomyosarcoma is a mesenchymal malignancy associated with the skeletal muscle
lineage and is also the most common pediatric soft tissue cancer. Between the two pediatric …

Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain

V Sirri, MP Leibovitch, SA Leibovitch - Oncogene, 2003 - nature.com
Rhabdomyosarcoma (RMS) has deregulated proliferation and is blocked in the
differentiation program despite Myf-5, MyoD and myogenin expression. Here we show that …

[HTML][HTML] CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG

Z Liu, X Zhang, H Lei, N Lam, S Carter… - Nature …, 2020 - nature.com
Embryonal rhabdomyosarcoma (ERMS) is a childhood cancer that expresses myogenic
master regulatory factor MYOD but fails to differentiate. Here, we show that the zinc finger …

Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic …

KL MacQuarrie, Z Yao, AP Fong, SJ Diede… - … and cellular biology, 2013 - Am Soc Microbiol
Rhabdomyosarcoma is a pediatric tumor of skeletal muscle that expresses the myogenic
basic helix-loop-helix protein MyoD but fails to undergo terminal differentiation. Prior work …

Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells

A Astolfi, C De Giovanni, L Landuzzi, G Nicoletti… - Gene, 2001 - Elsevier
Rhabdomyosarcoma is a soft tissue tumor committed to the myogenic lineage but arrested
prior to terminal differentiation. To identify new genes implicated in the block in myogenic …

[HTML][HTML] miR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells

KL MacQuarrie, Z Yao, JM Young, Y Cao, SJ Tapscott - Skeletal Muscle, 2012 - Springer
Background Similar to replicating myoblasts, many rhabdomyosarcoma cells express the
myogenic determination gene MyoD. In contrast to myoblasts, rhabdomyosarcoma cells do …

Rhabdomyosarcoma–working out the pathways

G Merlino, LJ Helman - Oncogene, 1999 - nature.com
Rhabdomyosarcomas constitute a collection of childhood malignancies thought to arise as a
consequence of regulatory disruption of skeletal muscle progenitor cell growth and …

[HTML][HTML] Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma

S Pomella, P Sreenivas, BE Gryder, L Wang… - Nature …, 2021 - nature.com
Rhabdomyosarcoma (RMS) is an aggressive pediatric malignancy of the muscle, that
includes Fusion Positive (FP)-RMS harboring PAX3/7-FOXO1 and Fusion Negative (FN) …